CliffBio

Cycle Pharmaceuticals

Patent cliffs & loss of exclusivity

Repurposed drugs, generics, formulation

Company

Legal NameCycle Pharmaceuticals Ltd.
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/cycle-pharmaceuticals
Facebook URLhttps://www.facebook.com/cyclepharma
Full AddressWeWork Floor 3 200 Portland St, Boston, MA 02114
Instagram URLhttps://www.instagram.com/cyclepharma/
LinkedIn URLhttps://www.linkedin.com/company/cycle-pharmaceuticals
Twitter URLhttps://twitter.com/cyclepharma

6 upcoming patent cliffs

DrugIngredientTypeCliff
  1. HARLIKUNITISINONESmall mol.Jun 2032
  2. NITYRNITISINONESmall mol.Jan 2035
  3. NITYRNITISINONESmall mol.Jan 2035
  4. NITYRNITISINONESmall mol.Jan 2035
  5. TASCENSO ODTFINGOLIMOD LAURYL SULFATESmall mol.Jan 2036
  6. TASCENSO ODTFINGOLIMOD LAURYL SULFATESmall mol.Jan 2036
  7. INDOMETHACININDOMETHACINSmall mol.—
  8. INDOMETHACININDOMETHACINSmall mol.—
  9. PIROXICAMPIROXICAMSmall mol.—
  10. PIROXICAMPIROXICAMSmall mol.—
  11. CIMETIDINE HYDROCHLORIDECIMETIDINE HYDROCHLORIDESmall mol.—
  12. QUINIDINE GLUCONATEQUINIDINE GLUCONATESmall mol.—
  13. CHLORPROMAZINE HYDROCHLORIDECHLORPROMAZINE HYDROCHLORIDESmall mol.—
  14. CHLORPROMAZINE HYDROCHLORIDECHLORPROMAZINE HYDROCHLORIDESmall mol.—
  15. CHLORPROMAZINE HYDROCHLORIDECHLORPROMAZINE HYDROCHLORIDESmall mol.—
  16. CHLORPROMAZINE HYDROCHLORIDECHLORPROMAZINE HYDROCHLORIDESmall mol.—
  17. CHLORPROMAZINE HYDROCHLORIDECHLORPROMAZINE HYDROCHLORIDESmall mol.—
  18. CIMETIDINECIMETIDINESmall mol.—
  19. CIMETIDINECIMETIDINESmall mol.—
  20. CIMETIDINECIMETIDINESmall mol.—
  21. QUINIDINE SULFATEQUINIDINE SULFATESmall mol.—
  22. QUINIDINE SULFATEQUINIDINE SULFATESmall mol.—
  23. RESERPINERESERPINESmall mol.—
  24. RESERPINERESERPINESmall mol.—

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Cycle Pharmaceuticals — patent cliffs & loss of exclusivity | CliffBio